JAK1 blocking peptide product blog
Tags: Blocking Peptide; JAK1; JAK1 blocking peptide;
The JAK1 jak1 (Catalog #MBS9229402) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The JAK1 jak1 product has the following accession number(s) (GI #215274013) (NCBI Accession #P23458.2) (Uniprot Accession #P23458). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Tyrosine kinase of the non-receptor type, involved in the IFN-alpha/beta/gamma signal pathway. Kinase partner for the interleukin (IL)-2 receptor.
Cellular Location: Endomembrane system; Peripheral membrane protein. Note: Wholly intracellular, possibly membrane associated. Tissue Location: Expressed at higher levels in primary colon tumors than in normal colon tissue. The expression level in metastatic colon tumors is comparable to the expression level in normal colon tissue. JAK1 also interacts with the following gene(s): IL2RB, IRS1, PTPN11, SOCS3, STAT1, STAT2, STAT3, STAT5A, STAT5B, STAT6. Blood, Bone, Bone Marrow, Brain, Heart, Liver, Lung, Muscle, Skin, Vascular tissues are correlated with this protein. The following patways have been known to be associated with this gene. Anemia, Carcinoma, Hepatocellular, Disease Models, Animal, Fibrosis, Inflammation, Liver Diseases, Liver Neoplasms, Lung Neoplasms, Necrosis, Neoplasms, Experimental are some of the diseases may be linked to JAK1 Blocking Peptide (C-term).